The ontogeny of estrogen receptors: brain and pituitary.
This study examines the prenatal and neonatal development of estrogen receptors in the central nervous system of the mouse. [3H]Diethylstilbestrol (DES) was injected into pregnant mice on days 4, 7, 10, 13, 14, 15 and 17 of gestation or into neonates. DES is an estrogen agonist that circumvents the alpha-fetoprotein barrier, thereby gaining access to intracellular estrogen receptors. Sixty minutes after injection whole embryos, fetuses or neonates were rapidly frozen and processed for autoradiography. Although the transplacental movement of the isotope was confirmed in all age groups evidence for nuclear estrogen receptors was not seen in the brain until day E14. On this day a few labeled cells first appeared in the basal hypothalamus, preoptic area, amygdala, midbrain and spinal cord. The number and the labeling intensity of target cells increased in each of these areas on days E15, E17 and P0. The first appearance of estrogen receptors closely follows the reported birthdates of neurons in these regions.
D000818:Animals; D000831:Animals, Newborn; D001345:Autoradiography; D001921:Brain / Q000196:embryology / Q000254:growth & development* / Q000378:metabolism; D004054:Diethylstilbestrol / Q000378:metabolism; D005260:Female; D008297:Male; D051379:Mice; D010902:Pituitary Gland / Q000196:embryology / Q000254:growth & development* / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism / Q000502:physiology*; D012727:Sex Characteristics
D011960:Receptors, Estrogen; D004054:Diethylstilbestrol